Characterization of dihydroartemisinin-resistant colon carcinoma HCT116/R cell line.
about
Anticancer properties of distinct antimalarial drug classesDevelopment of artemisinin compounds for cancer treatment.Qinghaosu (artemisinin): chemistry and pharmacology.Terpenoids: natural products for cancer therapy.Artemisinin as an anticancer drug: Recent advances in target profiling and mechanisms of action.Antitumor Research on Artemisinin and Its Bioactive Derivatives.
P2860
Characterization of dihydroartemisinin-resistant colon carcinoma HCT116/R cell line.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Characterization of dihydroartemisinin-resistant colon carcinoma HCT116/R cell line.
@ast
Characterization of dihydroartemisinin-resistant colon carcinoma HCT116/R cell line.
@en
type
label
Characterization of dihydroartemisinin-resistant colon carcinoma HCT116/R cell line.
@ast
Characterization of dihydroartemisinin-resistant colon carcinoma HCT116/R cell line.
@en
prefLabel
Characterization of dihydroartemisinin-resistant colon carcinoma HCT116/R cell line.
@ast
Characterization of dihydroartemisinin-resistant colon carcinoma HCT116/R cell line.
@en
P2093
P2860
P1476
Characterization of dihydroartemisinin-resistant colon carcinoma HCT116/R cell line.
@en
P2093
Ling-Hua Meng
Si-Meng Chen
P2860
P2888
P304
P356
10.1007/S11010-011-1072-2
P50
P577
2011-09-30T00:00:00Z
P6179
1031812405